Insider Transactions in Q2 2021 at Reata Pharmaceuticals Inc (RETA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
40,000
-13.45%
|
$5,680,000
$142.52 P/Share
|
|
Jun 14
2021
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
20,000
-7.06%
|
$2,880,000
$144.9 P/Share
|
|
Jun 14
2021
|
Colin John Meyer Chief Innovation Officer |
BUY
Conversion of derivative security
|
Direct |
5,000
+6.1%
|
-
|
|
Jun 09
2021
|
Elaine Castellanos VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
8,454
-19.01%
|
$1,200,468
$142.18 P/Share
|
|
Jun 09
2021
|
Elaine Castellanos VP, Chief Accounting Officer |
BUY
Conversion of derivative security
|
Direct |
8,454
+26.88%
|
-
|
|
Jun 07
2021
|
Elaine Castellanos VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,546
-4.92%
|
$225,716
$146.82 P/Share
|
|
Jun 07
2021
|
Elaine Castellanos VP, Chief Accounting Officer |
BUY
Conversion of derivative security
|
Direct |
1,546
+8.77%
|
-
|
|
May 26
2021
|
Elaine Castellanos VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
10,000
-40.74%
|
$1,240,000
$124.55 P/Share
|
|
May 26
2021
|
Elaine Castellanos VP, Chief Accounting Officer |
BUY
Conversion of derivative security
|
Direct |
10,000
+28.95%
|
-
|